Geneva, March 20 -- International Clinical Trials Registry received information related to the study (DRKS00039243) titled 'A Medically Evaluated Chatbot for Patients with Eosinophilic Esophagitis and Their Caregivers to Enhance Patient Empowerment' on Feb. 24.
Study Type: interventional
Study Design:
Allocation: Randomized controlled study
Masking: Open (masking not used)
Control: active
Assignment: parallel
Study design purpose: supportive care
Primary Sponsor: Universitatsklinikum Gießen
Condition:
K20.0
Eosinophilic esophagitis
Intervention:
Group 1: Patients and caregivers complete a baseline questionnaire at study entry. They are then provided access to the study-specific chatbot for three months. After this period, a f...